Registration Strip Icon for alerts Registrati per avvisi in tempo reale, portafoglio personalizzato e movimenti di mercato.

Angle Plc

AGL
11,00
-0,50 (-4,35%)
Ultimo aggiornamento: 14:26:53
Dati in Delay di 15 minuti
Borsa: Londra
Tipo: Azione Ordinaria
Valuta: GBX

Ultime notizie

Data Ora Fonte Titolo
15/11/202415:33ALNCNewsAngle stock surges as firm showcases new assay products
15/11/202408:00LSEG_NONAngle PLC Parsortix based PD-L1 assay showcased at AACR
15/11/202408:00LSEG_NONAngle PLC Research on HER2 assay kit showcased at AACR
13/11/202408:00LSEG_NONAngle PLC ANGLE presents two posters at EACR
11/11/202413:07ALNCNewsAngle notes use of Parsortix system in treatment resistance..
11/11/202408:00LSEG_NONAngle PLC Parsortix enriched CTC & ctDNA in NSCLC patients
17/10/202408:00LSEG_NONAngle PLC Publication demonstrates CTC profiling potential
26/9/202414:30ALNCNewsEARNINGS: Ebiquity bemoans poor conditions on swing to..
26/9/202408:01LSEG_NONAngle PLC 100th publication supporting Parsortix system use
26/9/202408:00LSEG_RNSAngle PLC Half-year Report
23/9/202408:00LSEG_RNSAngle PLC Exclusive agreement for DNA NGS panel
19/9/202415:44ALNCNewsIN BRIEF: Angle celebrates agreement with Recursion..
19/9/202408:00LSEG_NONAngle PLC Agreement with Recursion Pharmaceuticals
17/9/202408:00LSEG_RNSAngle PLC Notice of Interim Results and Webcast
23/8/202412:43ALNCNewsIN BRIEF: Angle hails publication of research data in..
22/8/202408:00LSEG_NONAngle PLC Data supporting FDA approval published in Journal
01/8/202408:00LSEG_NONAngle PLC Independent Parsortix study
18/7/202411:08LSEG_RNSAngle PLC Standard form for notification of major holdings
12/7/202416:38LSEG_RNSAngle PLC Standard form for notification of major holdings
11/7/202416:07LSEG_RNSAngle PLC Result of 2024 Annual General Meeting
21/6/202411:52ALNCNewsIN BRIEF: Angle says open offer raises proceeds of..
21/6/202408:00LSEG_RNSAngle PLC Result of open offer
18/6/202415:41LSEG_RNSAngle PLC Posting of 2023 Annual Report & Notice of the AGM
11/6/202408:00LSEG_NONAngle PLC Parsortix and assays being showcased at EACR 2024
06/6/202417:37LSEG_RNSAngle PLC Publication of Circular
05/6/202417:32ALNCNewsEARNINGS AND TRADING: STV sees advertising upturn; Angle..
05/6/202417:04LSEG_RNSAngle PLC Results of placing and subscription
05/6/202408:00LSEG_RNSAngle PLC Proposed Placing, Subscription and Open Offer
05/6/202408:00LSEG_RNSAngle PLC Preliminary Results
16/5/202421:09ALNCNewsTRADING UPDATES: Bens Creek considers administration; Nexxen..
16/5/202408:00LSEG_NONAngle PLC Study of ovarian cancer CTCs using Parsortix
03/5/202413:17ALNCNewsCORRECT: Angle shares up on assay development deal with..
03/5/202412:50ALNCNewsAngle shares up on assay development deal with AstraZenaca
03/5/202408:00LSEG_RNSAngle PLC New commercial agreement with large pharma
24/4/202411:32ALNCNewsAngle shares jump on supplier agreement with with..
24/4/202408:00LSEG_RNSAngle PLC New commercial agreement with AstraZeneca
22/4/202417:52ALNCNewsIN BRIEF: Angle granted patents in US and Europe for..
22/4/202408:00LSEG_RNSAngle PLC US and EU patents for innovative CellKeep™ slide
08/4/202408:00LSEG_NONAngle PLC Parsortix HER2 assay showcased at AACR 2024
22/3/202408:00LSEG_NONAngle PLC Parsortix at European breast cancer conference
22/1/202419:03ALNCNewsIN BRIEF: Angle highlights supportive data for DNA analysis..
22/1/202408:00RNSNONAngle PLC Potential utility in precision oncology
10/1/202413:57UKREGAngle PLC Standard form for notification of major holdings
04/1/202413:19ALNCNewsAngle shares soar following "breakthrough" cancer..
04/1/202410:10DJNAngle PLC Shares Rise on Cancer Patient Blood Sample..
04/1/202408:00UKREGAngle PLC Breakthrough clinical results
02/1/202409:51ALNCNewsIN BRIEF: Angle teams with Japan's Eisai in breast cancer..
02/1/202408:00UKREGAngle PLC Contract announcement with Eisai Inc.
11/12/202321:44ALNCNewsTRADING UPDATES: Ondine Biomedical raises GBP2.9 million via..
11/12/202308:00UKREGAngle PLC Broker Announcement
Apertura: 11,50 Min: 10,75 Max: 11,50
Chiusura: 11,50

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network